FOX 47 - Health News
Now, a major drug maker wants to sell them to healthy people, as a way to prevent heart disease.
Crestor, the second-best selling cholesterol medication, will begin a new marketing strategy, and they're doing it with the government's blessing.
About 40 million people in this country take cholesterol medications, but new guidelines, approved by the FDA, would open the pharmacy to 6.5 million more people -- people with no cholesterol problems and no sign of heart problems.
Some doctors are putting up some red flags.
Studies show statins can increase a patient's risk for diabetes, liver disease, and muscle aches.
Dr. David Shearer is a family physician with Dean Health. He says taking a pill is not always the solution, and people need to focus on preventative steps.
"Stopping smoking, losing weight, eating a balanced diet, these lifestyle modifications are risk-free," Dr. Shearer said.
Still, statin use is skyrocketing. Doctors wrote more than 200 million prescriptions for cholesterol drugs last year. Usage doubled over the last decade, but it remains to be seen whether these new marketing strategies will mean more people will take the drugs.
"My prediction is it will not be widely accepted by the medical community," said Dr. Matthew Wolff, UW Hospital cardiologist.
Dr. Wolff says prescribing statins to people with little to no risk factors won't have a significant health impact, and will likely end up costing a lot of money.
"I think that's where the controversy arises -- it applies to the risk, but maybe more importantly to the expense of the drug. When you talk about treating potentially millions of people, you're only going to see a modest reduction in heart attacks, strokes, and deaths in the United States," Dr. Wolff said.
Both Shearer and Wolff say best advice for people is to have a one-on-one conversation with their doctor.
The new Crestor label says it may be prescribed for men over 50, and women over 60, who have one risk factor like smoking or hypertension.
Sun. - Fri. on FOX 47 News at 9!
Top Health Headlines (foxnews.com)
|Placenta 'switch' that kickstarts labor may solve long-standing mystery|
As any 40-weeks'-pregnant woman can attest, predicting when labor might start is a dark art — which is to say, basically impossible. Now, a new study suggests that a genetic "switch" in the placenta might kick off the production of the hormones that start labor.
|Birth order peril: Firstborn women more likely to be obese|
Second-born siblings may argue that firstborns get all the glory, but there may be a health benefit to coming in second: Firstborn women may be more likely to be overweight or obese than their later-born sisters, according to a new study in Sweden.
|Contact lens makers take fight over price law to court|
Contact lens makers struggled Thursday to defend their pricing policies in a federal appeals case that could have wide-ranging effects on the $4 billion industry.
|Leading stem cell scientist cleared of misconduct charges|
Sweden's Karolinska Institute says a leading stem cell scientist accused of unethical behavior has been cleared of scientific misconduct though he sometimes acted without due care.
|Long working hours tied to stroke risk|
People who work at least 55 hours a week are significantly more likely to eventually suffer a stroke than people who work 35 to 40 hours a week, a recent study suggests.
Tonight on FOX 47
5:00pm Two and a Half Men
5:30pm Big Bang Theory
6:00pm Modern Family
6:30pm Big Bang Theory
9:00pm FOX 47 News at 9
9:35pm Modern Family
10:05pm Mike & Molly
10:35pm Mike & Molly
11:05pm Two and a Half Men
11:35pm The Simpsons